Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -438,054 | 72,097 | 36,618 | 15,861 | -3,850 |
| Depreciation Amortization | 4,599 | 14,428 | 10,539 | 6,791 | 3,358 |
| Accounts receivable | -20,973 | -40,628 | -41,474 | -29,980 | -2,770 |
| Accounts payable and accrued liabilities | -5,409 | 5,232 | -1,920 | -6,686 | -9,648 |
| Other Working Capital | 454,020 | -31,994 | -26,569 | -48,455 | -22,695 |
| Other Operating Activity | 26,759 | 55,274 | 61,667 | 40,564 | 12,490 |
| Operating Cash Flow | $20,942 | $74,409 | $38,861 | $-21,905 | $-23,115 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -170,176 | 113,419 | -61,842 | -38,485 | -39,816 |
| PPE Investments | -2,670 | -17,597 | -12,522 | -8,271 | -3,030 |
| Net Acquisitions | -375,507 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | -50,000 | 0 | 0 | 0 |
| Investing Cash Flow | $-548,353 | $45,822 | $-74,364 | $-46,756 | $-42,846 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 336,637 | N/A | N/A | N/A |
| Debt Repayment | -1,760 | -1,414 | -1,325 | -897 | -453 |
| Common Stock Issued | 26,359 | 51,386 | 38,364 | 30,242 | 18,241 |
| Financing Cash Flow | $24,599 | $386,609 | $37,039 | $29,345 | $17,788 |
| Exchange Rate Effect | 3,358 | -13,399 | -3,418 | -1,017 | 920 |
| Beginning Cash Position | 616,931 | 123,490 | 123,490 | 123,490 | 123,490 |
| End Cash Position | 117,477 | 616,931 | 121,608 | 83,157 | 76,237 |
| Net Cash Flow | $-499,454 | $493,441 | $-1,882 | $-40,333 | $-47,253 |
| Free Cash Flow | |||||
| Operating Cash Flow | 20,942 | 74,409 | 38,861 | -21,905 | -23,115 |
| Capital Expenditure | -2,670 | -17,597 | -12,522 | -8,271 | -3,030 |
| Free Cash Flow | 18,272 | 56,812 | 26,339 | -30,176 | -26,145 |